...
首页> 外文期刊>Cardiovascular Research >Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.
【24h】

Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.

机译:蛋白激酶Cα通过诱导血管内皮生长因子促进人内皮细胞的血管生成活性。

获取原文
获取原文并翻译 | 示例

摘要

AIMS: Protein kinase C (PKC) plays an important role in the regulation of angiogenesis. However, downstream targets of PKC in endothelial cells are poorly defined. METHODS AND RESULTS: mRNA expression of vascular endothelial growth factor (VEGF) was analysed by quantitative real-time RT-PCR in human umbilical vein endothelial cells (HUVEC) and HUVEC-derived EA.hy 926 cells. siRNA was used to knockdown PKC isoforms and VEGF. Matrigel tube formation assay was used to analyse the angiogenic activity of endothelial cells. Phorbol-12-myristate-13-acetate (PMA) enhanced the ability of HUVEC to organize into tubular networks when plated on Matrigel, a phenomenon that could be prevented by PKC inhibitors. PMA markedly increased the expression of VEGF in HUVEC and EA.hy 926 cells. The enhancement in VEGF expression was prevented by PKC inhibitors and by an inhibitor of the Erk1/2 pathway. PMA-induced tube formation was reduced by inhibition of the VEGF receptor kinase, or by VEGF knockdown. PMA led to an activation of PKC isoforms alpha, delta and epsilon in HUVEC. Knockdown of PKC alpha diminished PMA-induced VEGF expression and angiogenesis. Also endothelial progenitor cells isolated from human peripheral blood showed enhanced VEGF expression and improved angiogenic activity in response to PKC activation. Moreover, incubation of HUVEC with VEGF led to PKC alpha activation and PKC-dependent VEGF upregulation. CONCLUSIONS: PKC alpha activation promotes angiogenic activity of human endothelial cells. This is likely to be largely mediated by induction of VEGF. VEGF enhances its own expression via a PKC alpha-dependent positive feedback mechanism.
机译:目的:蛋白激酶C(PKC)在调节血管生成中起重要作用。但是,内皮细胞中PKC的下游目标定义不清。方法与结果:实时定量RT-PCR检测人脐静脉内皮细胞(HUVEC)和HUVEC衍生的EA.hy 926细胞中血管内皮生长因子(VEGF)的mRNA表达。 siRNA用于敲低PKC亚型和VEGF。基质胶管形成试验用于分析内皮细胞的血管生成活性。 Phorbol-12-肉豆蔻酸酯-13-乙酸酯(PMA)增强了HUVEC涂在Matrigel上时组织成管状网络的能力,而PKC抑制剂可以防止这种现象。 PMA明显增加了HUVEC和EA.hy 926细胞中VEGF的表达。 PKC抑制剂和Erk1 / 2途径的抑制剂阻止了VEGF表达的增强。 PMA诱导的管形成可通过抑制VEGF受体激酶或通过VEGF敲低而减少。 PMA导致HUVEC中PKC亚型α,δ和epsilon活化。击倒PKCα减少了PMA诱导的VEGF表达和血管生成。从人外周血中分离出的内皮祖细胞还显示出增强的VEGF表达和对PKC激活的反应所产生的血管生成活性。此外,HUVEC与VEGF的孵育导致PKCα激活和PKC依赖性VEGF上调。结论:PKCα激活可促进人内皮细胞的血管生成活性。这很可能主要是通过诱导VEGF介导的。 VEGF通过PKCα依赖性正反馈机制增强自身表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号